Study of Efficacy and Acceptability of Tetrabenazine in the Late Dyskinetic Syndrome With Neuroleptics: A Randomized, Parallel Group, Double-blind Placebo Controlled Multicentre Trial
Phase of Trial: Phase III
Latest Information Update: 14 Sep 2017
At a glance
- Drugs Tetrabenazine (Primary)
- Indications Drug-induced dyskinesia
- Focus Therapeutic Use
- Acronyms XELADYS
- 11 Sep 2017 Status changed from recruiting to completed.
- 30 Jan 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.
- 23 Jan 2017 Planned End Date changed from 1 May 2017 to 1 Jun 2017.